PROCEPT BioRobotics Corporation
Price
FilingsNewest: 8-K, Director or officer changeOct 2 →Insiders1 insider bought $10.5M in 7 open-market buys. 3 insiders sold $601,968, 2 of 11 sales on a 10b5-1 plan.→HoldersBlackRock 8.5%BNP PARIBAS ASSET MANAGEMENT Holding S.A. 4.9%Vanguard Portfolio 4.4%→PeersClosest companies: RXST, BVS, LUNG→
From the filings
Figures
- Revenue
- $337.3Mlast 12 months
- Net income
- −$14.3Mlast 12 months
- Operating cash flow
- −$70.1Mlast 12 months
- Cash and equivalents
- $227.9Mat the last balance sheet
- Total debt
- $51.7Mat the last balance sheet
- Shares outstanding
- 57.2M shareson issue